Season's Greetings

Published: 22-Dec-2010

Manufacturing Chemist would like to wish all our readers, contributors and advertisers the compliments of the season. We wish you all an exciting and successful 2011.

Manufacturing Chemist would like to wish all our readers, contributors and advertisers the compliments of the season. We wish you all an exciting and successful 2011.

We will resume sending out the email newsletters for the magazine in the New Year.

Until 2011...

See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Finance

Oncoinvent patent win and CellCarta deal highlight IP power in oncology innovation

Read more
New patent protection for Radspherin and a global exclusivity deal for Aspyre Lung underline how strong IP strategies are driving competitive advantage in cancer therapeutics and diagnostics

Trending Articles

  1. Roche wins CE mark for first blood-based immunoassay to identify ApoE4 Alzheimer's risk variant Roche's Elecsys ApoE4 test has received CE mark approval as the first in-vitro diagnostic immunoassay to detect the ApoE4 genetic variant from a simple blood sample, potentially eliminating the need for confirmatory DNA testing in Alzheimer's patients who do not carry the variant
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    From proof-of-concept to commercial reality: a turning point for microneedle drug delivery A 50% reduction in microarray patch production costs demonstrates that scalable, automated MAP manufacturing is now commercially viable — clearing a critical barrier to mainstream pharmaceutical adoption
  3. Destination Russia for new NYK Logistics warehouse <p>Logistics specialist NYK is expanding its market presence with the launch of new warehousing operation in Moscow, Russia.</p>
  4. 3PBIOVIAN and Colombia's National Cancer Institute partner to develop first locally produced oncology biosimilar The CDMO has signed an agreement with Colombia's Instituto Nacional de Cancerología to develop a biosimilar monoclonal antibody for an oncology indication, with technology transfer planned to enable domestic manufacturing
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Moving with speed and scale: innovative, material-sparing approaches to accelerate clinical development As early-stage drug development is often hindered by limited API supply, rising costs and tight timelines, material-sparing technologies are helping companies to progress faster with less

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Finance

Oncoinvent patent win and CellCarta deal highlight IP power in oncology innovation

New patent protection for Radspherin and a global exclusivity deal for Aspyre Lung underline how strong IP strategies are driving competitive advantage in cancer therapeutics and diagnostics
Manufacturing

Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription

With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
Pharma 5.0

Pharma 5.0: regular news and updates on manufacturingchemist.com

Our new dedicated website section will be your go-to hub for news on digital innovation within the pharmaceutical industry
Manufacturing

Mastering the art of oral solid dosage manufacturing: join our FREE webinar

Tackle the challenges you're facing in oral solid dosage (OSD) manufacturing
Manufacturing

Manufacturing Chemist launches webinar series - and seeks contributors

Manufacturing Chemist is launching of a 4-part webinar series, and we're kicking it off with Part 1 focusing on oral solid dose manufacturing. Showcase your expertise to a global audience by contributing to our webinar series
Media

Get ahead of the curve with a subscription

Keep abreast of significant pharmaceutical developments around the world
Drug Delivery

Manufacturing Chemist LIVE back for a third year running!

The annual pharmaceutical event is back on 25-26 May 2022 for professionals to gain the latest insights and keep up to date with best practice in drug production.
Subscribe now